Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inovio Pharmaceuticals

1.56
-0.0300-1.89%
Post-market: 1.570.0100+0.64%19:57 EDT
Volume:608.98K
Turnover:939.45K
Market Cap:57.20M
PE:-0.40
High:1.58
Open:1.58
Low:1.50
Close:1.59
Loading ...

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
05 Apr

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
03 Apr

Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
02 Apr

Inovio Pharmaceuticals Inc. Stock Slips 5.8%, Underperforms Competitors

Dow Jones
·
01 Apr

Moderna, Novavax, Other Vaccine Makers Retreat Following Resignation of FDA's Vaccines Chief

MT Newswires Live
·
01 Apr

Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
29 Mar

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
25 Mar

Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
21 Mar

Inovio Pharmaceuticals Inc. Stock Slips 6.7%, Underperforms Competitors

Dow Jones
·
20 Mar

Inovio Pharma Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
19 Mar

Inovio Pharma Price Target Maintained With a $3.00/Share by HC Wainwright & Co.

Dow Jones
·
19 Mar

RBC Capital Sticks to Their Hold Rating for Inovio Pharmaceuticals (INO)

TIPRANKS
·
19 Mar

RBC Cuts Price Target on Inovio Pharmaceuticals to $5 From $6, Keeps Sector Perform, Speculative Risk

MT Newswires Live
·
19 Mar

Inovio Pharmaceuticals Inc (INO) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...

GuruFocus.com
·
19 Mar

JMP Securities Sticks to Their Buy Rating for Inovio Pharmaceuticals (INO)

TIPRANKS
·
19 Mar

Inovio Pharmaceuticals Reports 2024 Financial Results

TIPRANKS
·
19 Mar

Inovio Pharmaceuticals (INO) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
19 Mar

Inovio Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
19 Mar

Inovio Pharmaceuticals Q4 2024 GAAP EPS $(0.65) Beats $(0.90) Estimate, Sales $117.000K Beat $30.000K Estimate

Benzinga
·
19 Mar

Inovio Pharmaceuticals Inc - on Track to Begin Rolling Submission of Bla in Mid-2025

THOMSON REUTERS
·
19 Mar